Dental Bone Graft Substitute : Analysis of Potential Market Opportunity Worth USD 659 million by 2025
This report aims to provide detailed insights
into the global dental
bone graft substitute market. It
provides valuable information on the type, procedure, application, and region
in the market. Furthermore, the information for these segments, by region, is
also presented in this report. Leading players in the market are profiled to
study their product offerings and understand the strategies undertaken by them
to be competitive in this market.
Expected Revenue Growth:
The global Dental Bone Graft Market size is estimated to be USD 450 million in
2020 and projected to reach USD
659 million by 2025, at a CAGR of 7.9%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690
Key Factors Driving Market Growth:
Growth in the dental bone graft substitute market is driven primarily by the
increasing prevalence of dental disorders, continuous product
commercialization, market availability & product affordability, rising
number of geriatric population, and growing public awareness related to
preventive care are driving the growth of the dental bone graft market.
The dental bone graft substitute market includes major Tier I and II
suppliers like Dentsply Sirona (US), Johnson & Johnson (US), Danaher
Corporation (US), Medtronic (Ireland),
Strauman (US), Zimmer Dental (US) and Geistlich Pharm (Switzerland). These suppliers have their
manufacturing facilities spread across regions such as North America and Europe. COVID-19
has impacted their businesses as well. Demand for dental bone graft substitute from
key end-users has significantly declined amidst the global COVID-19 pandemic.
Industry experts believe that COVID-19 will have short-term negative growth for
the market in 2020, but will experience normal growth as the dental bone graft
market gradually steadies by the end of 2020.
Demand for synthetic bone graft result in the segment occupying the high share
of the market
Synthetic bone graft segment owes a good market share in Dental bone graft
substitute market. Synthetic bones are derived from genetically unrelated
members of the same species, like cadaver bone. Using patient's own bone has traditionally
been the most preferred method bone grafting, however the increasing
technological advancements have increased the number of synthetic graft
options. The benefits of synthetic grafts include availability, sterility, and
reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and
there is no risk of any disease to get transferred. Because of these benefits
synthetic bone graft is the fastest growing type in the dental bone graft
market.
Xenograft estimated to be the largest growing market
Xenograft are estimated to be the largest growing segment in the dental bone
graft substitute market. The growth of this segment can be attributed to
source for allograft materials are highly scarce and technological advances of
xenograft materials are more recent for the dental application.
Europe is
the region of origin of implant dentistry; therefore, the penetration rate of
dental bone graft substitutes is very high in this region. The main factors
driving the growth of the European dental market are the increase in aging
population, governmental expenditure on oral healthcare across Europe, and the
high reimbursement rate—although limited to Germany, Sweden, and the Netherlands. Lots of opportunities for
dental bone graft market Growth In Europe.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690
Asia Pacific likely
to emerge as the fastest growing dental bone graft substitute market, globally
Asia Pacific is
estimated to be the fastest-growing market for dental bone graft substitute during
the forecast period. The Asia
Pacific market is driven principally by the rising geriatric
and obese population (coupled with the significant prevalence of orthopedic
& diabetes-related diseases in this population segment), increasing GDP and
healthcare expenditure in APAC countries, and growing public awareness.
Furthermore, increasingly localized product manufacturing, favorable government
regulations, and the focus of global product manufacturers on expanding their
presence in APAC countries are aiding the dental bone graft industry growth.
Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US),
Medtronic (Ireland),
Strauman (US), Zimmer Dental (US) and Geistlich Pharm (Switzerland) are
the key players in the global dental bone graft substitute global dental bone
graft substitute industry.
Comments
Post a Comment